Insulin-Like Growth Factor Binding Protein 7 (IGFBP7) Peptide
IGFBP7
Reactivity: Human
Host: Synthetic
BP, IHC, WB
-
- Target See all IGFBP7 products
- IGFBP7 (Insulin-Like Growth Factor Binding Protein 7 (IGFBP7))
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Immunohistochemistry (IHC), Western Blotting (WB)
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-IGFBP7 antibody (Catalog #: ARP48174_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- IGFBP7 (Insulin-Like Growth Factor Binding Protein 7 (IGFBP7))
- Background
-
IGFBP7 contains 1 Ig-like C2-type (immunoglobulin-like) domain, 1 IGFBP N-terminal domain and 1 Kazal-like domain. It binds IGF-I and IGF-II with a relatively low affinity. IGFBP7 stimulates prostacyclin (PGI2) production.
Alias Symbols: FSTL2, IGFBP-7, IGFBP-7v, MAC25, PSF, AGM, TAF, IBP-7, RAMSVPS, IGFBPRP1
Protein Interaction Partner: CCL21,CCL5,CXCL10,CCL21,CCL5,CXCL10,IGF1,IGF2,INHBA,INS,SDC1,VEGFA,VPS24,IGF1,IGF2,INS,VEGFA,VPS24
Protein Size: 282 - Molecular Weight
- 29 kDa
- Gene ID
- 3490
- NCBI Accession
- NM_001553, NP_001544
- UniProt
- Q16270
-
You are here:
